Lv418
502 积分 2026-06-25 加入
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
25天前
已完结
Recent advances in pretargeting strategies for cancer nuclear imaging and radionuclide therapy
29天前
已完结
Trop-2.2–Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model
29天前
已完结
In Vivo Rodent Studies with the Novel PET Tracer [18F]PGM028299: An Inhibitor of D-Amino Acid Oxidase
1个月前
已完结
Acridine-Based [68Ga]Ga- and [18F]AlF-Labeled PSMA Radiotracers Enabling High-Contrast PET Imaging with Minimized Undesired Retention
1个月前
已完结
Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates
1个月前
已完结
A FIRST 177LU/161TB/225AC RADIOIMMUNOCONJUGATE COMPARATIVE THERAPY STUDY ENABLED BY THE USE OF A VERSATILE BIFUNCTIONAL PYTA CHELATOR
1个月前
已完结
Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy
2个月前
已完结
Synthesis of 225Ac-PSMA-617 for Preclinical Use
2个月前
已完结
Treatment of Human Glioblastoma Multiforme in NRG Mice by Convection-Enhanced Delivery of EGFR-Targeted or Nontargeted Auger Electron-Emitting 197gHg-Labeled Gold Nanoparticles
2个月前
已完结
皖公网安备34019202002308
